US Map / Colorado
State CO

Clinical Trials in Colorado

Colorado is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Colorado and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 267 actively recruiting studies with Colorado sites out of 267 registered in total. The busiest research areas in Colorado are Solid Tumor, Ovarian Cancer, Acute Myeloid Leukemia. Leading sponsors running trials in the state include University of Colorado, Denver, Janssen Research & Development, LLC, National Cancer Institute (NCI). By stage, Colorado trials break down as Phase 1 (52), Phase 2 (80), Phase 3 (81), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
267
Recruiting Now
267
← Back to US Map
Top Conditions in Colorado
Solid Tumor (6)Ovarian Cancer (5)Acute Myeloid Leukemia (4)Cervical Cancer (4)Breast Cancer (4)Prostate Cancer (4)Heart Failure (4)Pancreatic Ductal Adenocarcinoma (PDAC) (3)Neoplasm Metastasis (3)Endometrial Cancer (3)Melanoma (3)Migraine (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 267 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 267. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Solid Tumor, Ovarian Cancer, Acute Myeloid Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT04559425 N/A
Recruiting
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block
Condition
Heart Block Complete
Enrollment
350 pts
Location
United States, Bulgaria, Canada
Sponsor
The Hospital for Sick Children
View Trial →
NCT05871970 Phase 2
Recruiting
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic...
Condition
Lymphatic Malformation
Enrollment
38 pts
Location
United States
Sponsor
Protara Therapeutics
View Trial →
NCT05143996 Phase 1, Phase 2
Recruiting
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Mye...
Condition
Relapsed/Refractory Acute Myeloid Leukemia (AML)
Enrollment
275 pts
Location
United States
Sponsor
Cullinan Therapeutics Inc.
View Trial →
NCT07223203 Phase 3
Recruiting
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients...
Condition
Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy
Enrollment
125 pts
Location
United States, Argentina, Australia
Sponsor
Alnylam Pharmaceuticals
View Trial →
NCT07259746 N/A
Recruiting
Study of Student Flourishing
Condition
Healthy
Enrollment
2,500 pts
Location
United States, Canada, New Zealand
Sponsor
Flourish Science, Inc.
View Trial →
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07223346 N/A
Recruiting
Latinas Integrating Fitness and Therapy
Condition
Stepped Care Cognitive Behavioral Therapy
Enrollment
20 pts
Location
United States
Sponsor
Colorado State University
View Trial →
NCT07008911 N/A
Recruiting
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
Condition
Aortic Valve Stenosis
Enrollment
200 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07015905 Phase 3
Recruiting
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee ...
Condition
Venous Thromboembolism (VTE)
Enrollment
2,000 pts
Location
United States, Bulgaria, Hungary
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07140016 Phase 1
Recruiting
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung...
Condition
Non-small Cell Lung Cancer (NSCLC)
Enrollment
40 pts
Location
United States, France, Spain
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,250 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05987644 Phase 1, Phase 2
Recruiting
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients Wi...
Condition
Lung Cancer
Enrollment
56 pts
Location
United States
Sponsor
Joshua Palmer
View Trial →
NCT06876714 Phase 3
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People W...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
1,524 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT07292298 Phase 2
Recruiting
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Resid...
Condition
Rectal Adenocarcinoma
Enrollment
44 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07630974 Phase 1, Phase 2
Recruiting
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
134 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06450041 Phase 2
Recruiting
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and G...
Condition
Neuroblastoma
Enrollment
62 pts
Location
United States
Sponsor
New Approaches to Neuroblastom
View Trial →
NCT07700966 N/A
Recruiting
A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With P...
Condition
Recessive Dystrophic Epidermolysis Bullosa
Enrollment
250 pts
Location
United States
Sponsor
Abeona Therapeutics, Inc
View Trial →
NCT06701669 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Parid...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
200 pts
Location
United States
Sponsor
PPD Development, LP
View Trial →
NCT05650229 Phase 2
Recruiting
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Condition
Primary Mitochondrial Disease
Enrollment
180 pts
Location
United States, Australia, Belgium
Sponsor
Pharming Technologies B.V.
View Trial →
NCT07455383 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolep...
Condition
Narcolepsy Type 1
Enrollment
150 pts
Location
United States, Australia, Belgium
Sponsor
Alkermes, Inc.
View Trial →
NCT06772623 Phase 1, Phase 2
Recruiting
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab ...
Condition
Non Small Cell Lung Carcinoma
Enrollment
252 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
View Trial →
NCT07227727 N/A
Recruiting
Endothelial Dysfunction After SCI
Condition
Spinal Cord Injuries
Enrollment
40 pts
Location
United States
Sponsor
Craig Hospital
View Trial →
NCT05344573 N/A
Recruiting
Optimizing Pulsatility During Cardiopulmonary Bypass
Condition
Endothelial Dysfunction
Enrollment
66 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07206056 Phase 1, Phase 2
Recruiting
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tul...
Condition
Progressive Metastatic Castrate Resistant Prostate Cancer
Enrollment
188 pts
Location
United States, Australia, Canada
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06874335 Phase 1
Recruiting
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
Condition
Solid Tumor
Enrollment
140 pts
Location
United States
Sponsor
Biohaven Therapeutics Ltd.
View Trial →
Page 9 of 11 — 267 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology